肠道微生物失衡在慢性便秘中作用的研究进展

基础医学与临床 ›› 2021, Vol. 41 ›› Issue (4): 593-597.

肠道微生物失衡在慢性便秘中作用的研究进展

杨晶晶, 陈嘉屿^*

中国人民解放军联勤保障部队第九四〇医院消化内科, 甘肃兰州 730000

收稿日期:2020-08-10 修回日期:2020-12-16 出版日期:2021-04-05 发布日期:2021-04-05
通讯作者: ^*chenjiayu65@163.com
基金资助:
军委后勤保障部卫生局保健专项(17BJZ25)

Research progress on the role of intestinal microbial imbalance in chronic constipation

YANG Jing-jing, CHEN Jia-yu^*

Department of Gastroenterology, the 940th Hospital of the Joint Logistics Support Force of People's Liberation Army of China, Lanzhou 730000, China

Received:2020-08-10 Revised:2020-12-16 Online:2021-04-05 Published:2021-04-05
Contact: ^*chenjiayu65@163.com

摘要/Abstract

摘要： 慢性便秘为功能性便秘的原型,其患病率随年龄的增加而逐渐升高。肠道微生物参与了慢性便秘的发生发展、病理生理等过程,其可调节胃肠道的运动功能,肠道微生物的动态平衡遭到破坏可导致慢性便秘的发生。

关键词: 慢性便秘, 肠道微生物, 机制

Abstract: Chronic constipation is the prototype of functional constipation, and its morbidity increases gradually with aging. Intestinal microorganisms are involved in the occurrence, development, pathophysiology and other processes of chronic constipation. They can regulate the motor function of the gastrointestinal tract, and the destruction of the dynamic balance of intestinal microorganisms can lead to the occurrence of chronic constipation.

Key words: chronic constipation, intestinal microorganism, mechanism

中图分类号:

R574

杨晶晶, 陈嘉屿. 肠道微生物失衡在慢性便秘中作用的研究进展[J]. 基础医学与临床, 2021, 41(4): 593-597.

YANG Jing-jing, CHEN Jia-yu. Research progress on the role of intestinal microbial imbalance in chronic constipation[J]. Basic & Clinical Medicine, 2021, 41(4): 593-597.

参考文献

[1] 中华医学会消化病学分会胃肠动力学组,中华医学会消化病学分会功能性胃肠病协作组.中国慢性便秘专家共识(2019,广州)[J]. 中华消化杂志,2019,39:577-598.
[2] Aziz I, Whitehead WE, Palsson OS, et al. An approach to the diagnosis and management of Rome IV functional disorders of chronic constipation[J]. Expert Rev Gastroenterol Hepatol, 2020, 14 :39-46.
[3] 张静, 王肖枭, 周怡, 等. 肠道菌群与疾病相关性的研究进展[J]. 基础医学与临床, 2020, 40: 243-247.
[4] Wang Y, Dilidaxi D, Wu Y, et al. Composite probiotics alleviate type 2 diabetes by regulating intestinal microbiota and inducing GLP-1 secretion in db/db mice[J]. Biomed Pharmacother, 2020, 125: 109914.
[5] Van Mill MJ, Koppen IJN, Benninga MA. Controversies in the management of functional constipation in children[J]. Curr Gastroenterol Rep, 2019, 21: 23.
[6] D'Alessandro G, Antonangeli F, Marrocco F, et al. Gut microbiota alterations affect glioma growth and innate immune cells involved in tumor immunosurveillance in mice[J]. Eur J Immunol, 2020, 50: 705-711.
[7] Seroka B, Lotowski Z, Hryniewicka A, et al. Synthesis of new cisplatin derivatives from bile acids[J]. Molecules, 2020, 25: 655.
[8] Zhao L, Yang W, Chen Y, et al. A Clostridia-rich microbiota enhances bile acid excretion in diarrhea-predominant irritable bowel syndrome[J]. J Clin Invest, 2020, 130:438-450.
[9] Strandwitz P. Neurotransmitter modulation by the gut microbiota[J]. Brain Res, 2018, 1693: 128-133.
[10] Vincent AD, Wang XY, Parsons SP, et al. Abnormal absorptive colonic motor activity in germ-free mice is rectified by butyrate, an effect possibly mediated by mucosal serotonin[J]. Am J Physiol Gastrointest Liver Physiol, 2018, 315: G896-G907.
[11] Laverdure R, Mezouari A, Carson MA, et al. A role for methanogens and methane in the regulation of GLP-1[J]. Endocrinol Diabetes Metab, 2018, 1.doi: 10.1002/edm2.6.
[12] Chaudhary PP, Conway PL, Schlundt J. Methanogens in humans: potentially beneficial or harmful for health[J]. Appl Microbiol Biotechnol, 2018, 102: 3095-3104.
[13] Weltens N, Iven J, Van Oudenhove L, et al. The gut-brain axis in health neuroscience: implications for functional gastrointestinal disorders and appetite regulation[J]. Ann N Y Acad Sci, 2018, 1428: 129-150.
[14] Riezzo G, Chimienti G, Orlando A, et al. Effects of long-term administration of lactobacillus reuteri DSM-17938 on circulating levels of 5-HT and BDNF in adults with functional constipation[J]. Benef Microbes, 2019, 10: 137-147.
[15] Amano T, Ariga H, Kurematsu A ,et al. Effect of 5-hydroxytryptamine receptor 4 agonist mosapride on human gastric accommodation[J]. Neurogastroenterol Motil, 2015,27:1303-1309.
[16] 徐斌, 周进, 鲁明, 等. 曲美布丁联合复方阿嗪米特对功能性消化不良患者胃蛋白酶原及胃泌素水平的影响[J]. 中国医药, 2019,14: 1531-1534.
[17] 王玮. Ghrelin, GHRP-6 和胃动素对大鼠胃肠动力调控研究[D]. 青岛:青岛大学,2017:25-27.
[18] Jiang H, Dong J, Jiang S, et al. Effect of durio zibethinus rind polysaccharide on functional constipation and intestinal microbiota in rats[J]. Food Res Int, 2020. doi.org/10.1016/j.foodres.2020.109316.
[19] Bains M, Laney C, Wolfe AE, et al. Vasoactive intestinal peptide deficiency is associated with altered gut microbiota communities in male and female C57BL/6 mice[J]. Front Microbiol, 2019, 10: 2689.
[20] Zhang SL, Wang SN, Miao CY. Influence of microbiota on intestinal immune system in ulcerative colitis and its intervention[J]. Front Immunol, 2017, 8: 1674.
[21] Fitzgerald KA, Kagan JC. Toll-like receptors and the control of immunity[J]. Cell, 2020,180:1044-1066.
[22] Guo M, Yao J, Yang F, et al. The composition of intestinal microbiota and its association with functional constipation of the elderly patients[J]. Future Microbiol, 2020, 15: 163-175.